Member Info for DireCons

Https://probiotixhealth-ir.com/news/archive/2026/260526.asp

Probably burned out with hope FS. We needed to see a profit 5 years ago, but all that's been happening is draining the SBTX credit card to keep the lights on. I hope it comes good I really do, but I've written off my holding as a loss, as I can't see what could restore the thousands I've lost because I believed the hype. At least SOH and his family have been taking a nice salary though?

I hope your last message made sense in your own head curtain boy.

Thanks Aquae.

Aquae, if you don't mind me asking, where did you buy it and do you have a link to it?

Tia.

Who is Mind Pete?

Expect nothing but can-kicking, could, would, should, according to this or that data, potentially, possibly, metric tonnes... bla bla bla.

Has his lad finished uni yet?

Https://www.in-cosmetics.com/global/en-gb/exhibitor-directory/product-directory/product-details.exh-21bef431-1f47-42f7-aa0e-2f5b31158ce7.zenakine.pro-37ef950f-4d28-4c95-ab2c-5cc0592c7924.html#/

I think the old curtain boy is struggling with the digestification of important information. Instead of reading the post properly, he scans it with the intention of rushing to counter instead of just agreeing.

Maybe your curtains need a wash old boy?

I should add that the current quotes for PBX are 7p vs 9p

"I accept it's Aquis and that spread is prohibitive." Prohibitive being the operative word? Why would anyone spend, for example £10k and then suffer an immediate 28% loss?

I don't get Aquis at all. Don't they want a market?

Yes lol, my mistake. They were first listed as Ceres Media in 2011, then Ducat Ventures until August 2014 when;

Change of name to OptiBiotix Health plc

Ducat Ventures plc (AIM: DUC), which will become a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes, confirms that it's proposed change of name to OptiBiotix Health plc has now been registered at Companies House and is therefore effective.

So nearly 12 years. Feels like decades.

'This share seems to be constantly barraged with negative snipes by old holders'. Do you blame us? After 15 years of jam tomorrow, you would expect a bit of Wharreva!!

For the record, I haven't sold because it's not worth it. Just clinging on to the wreckage hoping a deal for the fabled 'Sweetbiotix' actually arrives before I die of old age.

Meanwhile, way back in March 2024;

RNS Number : 5803G

OptiBiotix Health PLC

13 March 2024

Stephen O'Hara, CEO of OptiBiotix, commented: "We are pleased to announce this agreement with Morepen, a well-known and trusted supplier to pharmacies, physicians, and retail customers across India. Morepen brings an extensive sales team with experience of highly differentiated scientific products and countrywide access to a network of around 500,000 pharmacies across India. Based on current forecasts, the Directors anticipate this agreement could contribute in the region of £6-7 million revenue per annum in the next four to five years."

He could have said "It's dragging on and on, and it looks as though it will come to nothing, just like the vast majority of the partnerships that we've signed over the last 15 years."

Time ran out about 5 years ago. Just a lifestyle business for the OH family now.

Bel, surely Winclove manufacture the Axis products in the Netherlands and Croda manufacture Zenakine in Widnes?

Have you got your wires crossed?

Roll on 2026!

Key Sales & Performance Data (As of 2024/2025 Reports):

Consumer Care Performance: Croda's Consumer Care sector, which includes Matrixyl, achieved a "standout performance" in 2024, with sales rising 7% at constant currency to £920.0 million.

Beauty Actives Growth: Beauty Actives—the business unit that houses Matrixyl—grew by 6% in 2024, led by strong performance in Asia (+16%) and with local & regional (L&R) customers.

High Demand: Matrixyl™ and other Sederma peptides are formulated into a significant portion of anti-aging products, with industry-leading efficacy and continued high demand.

Innovation-Led Sales: New and Protected Products (NPP), which includes advanced Matrixyl variations, grew by 6% in 2024, making up 35% of total Group sales.

2025 Outlook: Fragrances and Flavours (F&F) and Beauty Actives continue to show strong growth trends, with Beauty Actives sales growing in the high single-digits or double-digits in key markets during early 2025.

Indeed mart, ironic really. They have a long way to get back to the 20p float price, so that could be a hindrance too.

Watch out for SOH dipping in to keep the lights on at OPTI.

You forgot a ? at the end of your first sentence.

Always look after your eyes. Always wear shades whenever it's sunny, summer or winter.